You are here

Eli Lilly

Eli Lilly retakes innovation crown, while Bristol Myers rates most inventive pharma in annual study

Fierce Pharma

Thu, 04/22/21 - 11:33 pm

Lilly to seek first approval of an autoimmune drug for hair loss

BioPharma Dive

Wed, 04/21/21 - 11:26 pm

alopecia areata

clinical trials

A new market beckons for Alzheimer’s blood tests

EP Vantage

Mon, 04/19/21 - 11:12 am

Alzheimer's disease

Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab

Reuters

Fri, 04/16/21 - 09:48 am

Eli Lilly axes 163 Dermira staffers, shutters Menlo Park site as it closes in around Dupixent rival lebrikizumab

Endpoints

Thu, 04/15/21 - 10:39 am

Lilly, Arch join Deerfield in backing new gene therapy biotech Jaguar

BioPharma Dive

Tue, 04/13/21 - 10:14 pm

Jaguar Gene Therapy

Arch Venture Partners

With variants spreading, Eli Lilly cuts solo COVID-19 antibody out of its U.S. supply deal

Fierce Pharma

Tue, 04/13/21 - 10:35 am

bamlanivimab-etesevimab

5 takeaways from AACR, one of the year's top meetings on cancer drugs

BioPharma Dive

Mon, 04/12/21 - 11:34 pm

Bristol Myers Squibb

Pharma's pandemic reputation gains score a 'most-improved' medal in annual ranking

Fierce Pharma

Mon, 04/12/21 - 10:58 pm

pharma industry

Bristol Myers Squibb

Lilly gene-targeted drug shows potential for use across cancers

BioPharma Dive

Sun, 04/11/21 - 11:51 pm

clinical trials

Lilly claims promising finding in failed study of COVID-19 drug

BioPharma Dive

Thu, 04/8/21 - 07:40 pm

Series of JAK inhibitor delays may signal an upcoming FDA adcomm

Endpoints

Thu, 04/8/21 - 11:10 am

FDA pushes eczema decision for Eli Lilly's Olumiant, Pfizer's abrocitinib back 3 months — raising more questions for the JAK class

Endpoints

Wed, 04/7/21 - 10:30 am

Eli Lilly, GlaxoSmithKline-Vir release positive but difficult-to-interpret combo antibody data

Endpoints

Mon, 03/29/21 - 10:52 am

Vir Biotechnology

clinical trials

Ex-lobbyist sues Eli Lilly alleging sexual discrimination, harassment

Reuters

Mon, 03/29/21 - 10:47 am

gender discrimination

FDA Advisory Committee Raises Objections to Pfizer and Eli Lilly’s Tanezumab

BioSpace

Thu, 03/25/21 - 10:47 pm

advisory panels

Will Another Alzheimer's Disease Drug Bite the Dust After Lilly's Latest Results?

Motley Fool

Wed, 03/24/21 - 10:14 am

Alzheimer's disease

Pfizer has run 41 trials over 15 years for tanezumab. As adcomm nears, the FDA remains unimpressed — and more than a little worried

Endpoints

Mon, 03/22/21 - 10:42 am

advisory panels

Eli Lilly’s Covid-19 drug bamlanivimab is no longer distributed in 3 states because of a variant, Woodcock says

Endpoints

Wed, 03/17/21 - 11:34 pm

COVID-19 variants

Court win for Eli Lilly halts HHS’s drug discount rule

Endpoints

Wed, 03/17/21 - 10:42 am

Pages